期刊文献+

磷脂和羟丙基-β-环糊精对葛根素溶解度的影响 被引量:4

Effect of phospholipid and hydroxypropyl-β-cyclodextrin on solubility of puerarin
下载PDF
导出
摘要 目的将葛根素制成两相及三相分散体系,以提高葛根素的体外溶出速率。方法分别以磷脂和羟丙基-β-环糊精为载体,制备两相固体分散体和包合物,再将磷脂加入到葛根素-羟丙基-β-环糊精中制备三相分散体,分别进行溶解度和体外溶出度实验。对两相固体分散体、包合物和三相分散体进行红外扫描和差示扫描量热分析。结果当葛根素和磷脂的质量比为1∶2时制备的固体分散体葛根素的溶解度为6.54 g/L,包含物中葛根素溶解度为84.03 g/L,三相分散体中葛根素的溶解度为94.41 g/L。体外溶出结果显示15 min时,三相分散体中葛根素的累积溶出百分率达到98.34%。结论磷脂和羟丙基-β-环糊精对葛根素的溶出度具有协同作用。 AIM To prepare binary and ternary complexes of puerarin to evaluate their dissolution. METH- ODS Phospholipid (PL) and hydroxypropyl-β-cyclodextrin (HP-β-CD) were used as carrier to prepare binary solid dispersion and binary inclusion complex. Ternary complexes systems were obtained by adding phospholipid to puerarin-HP-β-CD ( 1 : 1 ) systems. All systems were examined for solubility and dissolution properties, and char- acterized by FT-IR and DSC. RESULTS The solubility of puerarin in binary solid dispersion (puerarin : PL of 1 : 2, m/m) was 6.54 g/L, and in binary inclusion complex was 84.03 g/L, while in ternary complexes systems reached 94. 41 g/L. The percent of cumulative dissolution of ternary complexes systems in 15 min was 98.34% . CONCLUSION The synergistic effect between cyclodextrin and phospholipid makes the dissolution and solubility of puerarin increase.
出处 《中成药》 CAS CSCD 北大核心 2013年第10期2130-2133,共4页 Chinese Traditional Patent Medicine
基金 浙江省国际合作项目(2009C14001) 国家自然科学基金(21006097 21176222 21276237) 浙江省自然科学基金(Y12B060048)
关键词 葛根素 羟丙基-Β-环糊精 磷脂 三相分散体 puerarin hydroxypropyl-β-cyclodextrin phospholipid ternary complexes
  • 相关文献

参考文献13

二级参考文献48

  • 1秦文,董兴兵,杨勤.葛根素的临床应用新进展[J].中国药业,2004,13(7):75-76. 被引量:13
  • 2吴燕红,苏子仁,赖小平,林吉.愈风宁心片中葛根素在Beagle犬体内药动学研究[J].中成药,2006,28(2):215-218. 被引量:12
  • 3国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 4朱秀媛 苏业成 等.葛根素的药代动力学[J].药学学报,1979,17(6):349-356.
  • 5吴建梅 陈大为 孙波 等.天然活性成分磷脂复合物药学研究进展[J].中国药学杂志,1997,18(2):62-62.
  • 6[2]中国药科大学.中药辞海(第三卷)[M].北京:中国医药科技出版社,1995:699-707.
  • 7中华人民共和国卫生部药典委员会.中华人民共和国药典(一部)[M].北京:化学工业出版社,2005.212.
  • 8满伟,李文丽,刘丽.葛根素注射液穴位注射治疗慢性咽炎疗效观察[J].时珍国医国药,2007,18(9):2324-2324. 被引量:12
  • 9Gabetta B,Bombardelli E,Pifferl G.Complexes of flavanolignanes with phospholipids,preparation thereof and pharmaceutical compositions [P].Eur Pat Appl 0,209,038.1987-01-21
  • 10Wu J, Chen D, Zhang R. Study on the bioavailability of baicalin-phospholipid complex by using HPLC [J]. Biomed Chromatogr ,1999,13(7):493

共引文献126

同被引文献41

  • 1李喆,邓英杰,王秀敏,张修宇.辅酶Q_(10)脂质体的制备及质量考察[J].中国医院药学杂志,2006,26(6):667-669. 被引量:3
  • 2李颖,潘卫三,陈士林,杨大坚,陈新滋,徐宏喜.葛根素磷脂复合物的制备及其固体分散体研究[J].中国药学杂志,2006,41(15):1162-1167. 被引量:41
  • 3崔升淼,赵春顺,何仲贵.葛根黄酮自微乳化软胶囊的制备和溶出度的考察[J].中成药,2007,29(7):993-996. 被引量:11
  • 4Rikisha B,Anuradha P,Hetal D,et al.Formulation and evalution of irbesartan liquisolid tablets[J].Int J Pharm Sci Rev Res,2011,9(2):32-37.
  • 5Patel V P,Patel N M.Dissolution enhancement of glipizide using liquisolid tablet technology[J].Indian Drugs,2008,45(4):318-323.
  • 6方士英,吴虹,徐茂红,等.葛根黄酮对心脑血管系统作用及临床应用的研究进展[J].医学前沿,2011(23):193-194.
  • 7Kavitha K,Kotha L,Raju N S,Ganesh N S,et al.Effect of dissolution rate by liquisolid compact approach:An overview[J].Der Pharmacia Lett,2011,3(1):71-83.
  • 8Nokhodchia A,Aliakbara R,Desaia S,et al.Liquisolid compacts:The effect of cosolvent and HPMC on the ophylline release[J].Biointerfaces,2010,79(1):262-269.
  • 9Bindu M B,Kusum B,David B,Novel strategies for poorly water soluble drugs.[J].Int J Pharm Sci Rev Res,2010,4(3):76-84.
  • 10Rania F H,Mohammed K A.Enhancement of famotidine dissolution rate through liquisolid tablets formulation:In vitro and in vivo evaluation[J].Eur J Pharm Biopharm 2008,69(8):993-1003.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部